267 related articles for article (PubMed ID: 28334430)
1. Radiofrequency ablation using a 10-mm target margin for small hepatocellular carcinoma in patients with liver cirrhosis: A prospective randomized trial.
Liao M; Zhong X; Zhang J; Liu Y; Zhu Z; Wu H; Zeng Y; Huang J
J Surg Oncol; 2017 Jun; 115(8):971-979. PubMed ID: 28334430
[TBL] [Abstract][Full Text] [Related]
2. Recurrence-free survival after radiofrequency ablation of hepatocellular carcinoma. A registry report of the impact of risk factors on outcome.
Zytoon AA; Ishii H; Murakami K; El-Kholy MR; Furuse J; El-Dorry A; El-Malah A
Jpn J Clin Oncol; 2007 Sep; 37(9):658-72. PubMed ID: 17766723
[TBL] [Abstract][Full Text] [Related]
3. Radiofrequency ablation of hepatocellular carcinoma as first-line treatment: long-term results and prognostic factors in 162 patients with cirrhosis.
Lee DH; Lee JM; Lee JY; Kim SH; Yoon JH; Kim YJ; Han JK; Choi BI
Radiology; 2014 Mar; 270(3):900-9. PubMed ID: 24475823
[TBL] [Abstract][Full Text] [Related]
4. Radiofrequency ablation for intrahepatic recurrent hepatocellular carcinoma: long-term results and prognostic factors in 168 patients with cirrhosis.
Lee DH; Lee JM; Lee JY; Kim SH; Han JK; Choi BI
Cardiovasc Intervent Radiol; 2014 Jun; 37(3):705-15. PubMed ID: 23912493
[TBL] [Abstract][Full Text] [Related]
5. Radiofrequency ablation for hepatocellular carcinoma measuring 2 cm or smaller: results and risk factors for local recurrence.
Kono M; Inoue T; Kudo M; Chishina H; Arizumi T; Takita M; Kitai S; Yada N; Hagiwara S; Minami Y; Ueshima K; Nishida N; Murakami T
Dig Dis; 2014; 32(6):670-7. PubMed ID: 25376283
[TBL] [Abstract][Full Text] [Related]
6. Significant long-term survival after radiofrequency ablation of unresectable hepatocellular carcinoma in patients with cirrhosis.
Raut CP; Izzo F; Marra P; Ellis LM; Vauthey JN; Cremona F; Vallone P; Mastro A; Fornage BD; Curley SA
Ann Surg Oncol; 2005 Aug; 12(8):616-28. PubMed ID: 15965731
[TBL] [Abstract][Full Text] [Related]
7. Percutaneous radiofrequency ablation as first-line treatment for small hepatocellular carcinoma: results and prognostic factors on long-term follow up.
Waki K; Aikata H; Katamura Y; Kawaoka T; Takaki S; Hiramatsu A; Takahashi S; Toyota N; Ito K; Chayama K
J Gastroenterol Hepatol; 2010 Mar; 25(3):597-604. PubMed ID: 20074153
[TBL] [Abstract][Full Text] [Related]
8. Radiofrequency ablation for the treatment of hepatocellular carcinoma with decompensated cirrhosis.
Wakuta A; Nouso K; Kariyama K; Nishimura M; Kishida M; Wada N; Mizushima T; Higashi T; Tanimoto M
Oncology; 2011; 81(1):39-44. PubMed ID: 21912196
[TBL] [Abstract][Full Text] [Related]
9. Noninvasive fibrosis indices predict intrahepatic distant recurrence of hepatitis B-related hepatocellular carcinoma following radiofrequency ablation.
Seo JY; Kim W; Kwon JH; Jin EH; Yu SJ; Kim HY; Jung YJ; Kim D; Kim YJ; Yoon JH; Lee HS
Liver Int; 2013 Jul; 33(6):884-93. PubMed ID: 23461618
[TBL] [Abstract][Full Text] [Related]
10. The minimal ablative margin of radiofrequency ablation of hepatocellular carcinoma (> 2 and < 5 cm) needed to prevent local tumor progression: 3D quantitative assessment using CT image fusion.
Kim YS; Lee WJ; Rhim H; Lim HK; Choi D; Lee JY
AJR Am J Roentgenol; 2010 Sep; 195(3):758-65. PubMed ID: 20729457
[TBL] [Abstract][Full Text] [Related]
11. Long-term follow-up outcome of patients undergoing radiofrequency ablation for unresectable hepatocellular carcinoma.
Machi J; Bueno RS; Wong LL
World J Surg; 2005 Nov; 29(11):1364-73. PubMed ID: 16240062
[TBL] [Abstract][Full Text] [Related]
12. Increased survival in hepatocellular carcinoma with iodine-125 implantation plus radiofrequency ablation: a prospective randomized controlled trial.
Chen K; Chen G; Wang H; Li H; Xiao J; Duan X; He J; He K; Xiang G
J Hepatol; 2014 Dec; 61(6):1304-11. PubMed ID: 25064436
[TBL] [Abstract][Full Text] [Related]
13. Early-stage hepatocellular carcinoma in patients with cirrhosis: long-term results of percutaneous image-guided radiofrequency ablation.
Lencioni R; Cioni D; Crocetti L; Franchini C; Pina CD; Lera J; Bartolozzi C
Radiology; 2005 Mar; 234(3):961-7. PubMed ID: 15665226
[TBL] [Abstract][Full Text] [Related]
14. Analysis of recurrence pattern and its influence on survival outcome after radiofrequency ablation of hepatocellular carcinoma.
Ng KK; Poon RT; Lo CM; Yuen J; Tso WK; Fan ST
J Gastrointest Surg; 2008 Jan; 12(1):183-91. PubMed ID: 17874276
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic effectiveness of echo-guided percutaneous radiofrequency ablation therapy with a LeVeen needle electrode in hepatocellular carcinoma.
Solmi L; Nigro G; Roda E
World J Gastroenterol; 2006 Feb; 12(7):1098-104. PubMed ID: 16534852
[TBL] [Abstract][Full Text] [Related]
16. Surgical resection versus percutaneous radiofrequency ablation in the treatment of hepatocellular carcinoma on cirrhotic liver.
Vivarelli M; Guglielmi A; Ruzzenente A; Cucchetti A; Bellusci R; Cordiano C; Cavallari A
Ann Surg; 2004 Jul; 240(1):102-7. PubMed ID: 15213625
[TBL] [Abstract][Full Text] [Related]
17. [Results of percutaneous radiofrequency ablation of hepatocellular carcinoma in patients with cirrhosis aged 75 years and over].
Lahbabi M; N'kontchou G; Aout M; Vicaud E; Ganne N; Trinchet JC; Seror O; Beaugrand M
Rev Med Interne; 2012 Mar; 33(3):128-33. PubMed ID: 22226387
[TBL] [Abstract][Full Text] [Related]
18. Repeated radiofrequency ablation for management of patients with cirrhosis with small hepatocellular carcinomas: a long-term cohort study.
Rossi S; Ravetta V; Rosa L; Ghittoni G; Viera FT; Garbagnati F; Silini EM; Dionigi P; Calliada F; Quaretti P; Tinelli C
Hepatology; 2011 Jan; 53(1):136-47. PubMed ID: 20967759
[TBL] [Abstract][Full Text] [Related]
19. Radiofrequency ablation of hepatocellular carcinoma as bridge therapy to liver transplantation: A 10-year intention-to-treat analysis.
Lee MW; Raman SS; Asvadi NH; Siripongsakun S; Hicks RM; Chen J; Worakitsitisatorn A; McWilliams J; Tong MJ; Finn RS; Agopian VG; Busuttil RW; Lu DSK
Hepatology; 2017 Jun; 65(6):1979-1990. PubMed ID: 28170115
[TBL] [Abstract][Full Text] [Related]
20. Partial hepatectomy with wide versus narrow resection margin for solitary hepatocellular carcinoma: a prospective randomized trial.
Shi M; Guo RP; Lin XJ; Zhang YQ; Chen MS; Zhang CQ; Lau WY; Li JQ
Ann Surg; 2007 Jan; 245(1):36-43. PubMed ID: 17197963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
